Thymosin alpha 1 TA10 10mg*10vials

Thymosin α1 TA10 10mg*10 vials is a highly effective, upgraded immunomodulatory peptide, belonging to the immunopeptide class. It is an enhanced mid-range product, an improved version of the basic TA5 5mg formulation. TA10 retains the bioactive sequence, ultra-low immunogenicity, and excellent biocompatibility of the thymosin α1 series derived from the natural thymus. Its double-optimized 10mg concentration comprehensively enhances its core immunomodulatory efficacy. Overcoming the limitations of low-dose formulations, TA10 more effectively promotes T lymphocyte maturation, achieving a more balanced dual immunomodulation and more thoroughly correcting inflammatory immune imbalances. It stably activates the physiological functions of immune cells without overstimulating immune pathways, making it perfectly suited for preclinical research scenarios such as modeling moderate immunodeficiency, intervening in inflammatory immune disorders, validating efficient host defense mechanisms, and studying the synergistic immune enhancement of peptide compounds. It serves as a core upgraded standard research material for advanced immunopharmacology and adaptive immune mechanism research.

Product Functions and Research Value

Through in-depth and systematic laboratory studies, thymosin α1 TA10 10mg has demonstrated enhanced multidimensional immune homeostasis regulation. Its core upgraded research advantages encompass four enhanced dimensions: significantly promoting the differentiation and maturation of multiple T cell subsets, rebuilding adaptive immune function; strengthening the dual balance regulation of innate and adaptive immunity, effectively correcting immune biases; deeply optimizing the inflammatory cytokine spectrum, reducing moderate immune-mediated inflammatory damage; and comprehensively enhancing the body's defensive immune activity under stress and immunosuppression. Compared to the mild regulatory effects of TA5, TA10 10mg exhibits faster experimental response, stronger immune remodeling capacity, and more durable homeostatic efficacy. It can effectively improve moderate immunosuppression, abnormal cytokine secretion, and persistent low-grade immune inflammation that are insensitive to low-dose regimens. It can precisely repair damaged immune cell function, reverse immune system dysfunction, and significantly enhance the body's ability to resist external immune challenges. The 10mg high-efficiency balanced formulation exhibits outstanding experimental variability and stable long-term efficacy, making it an ideal choice for medium-dose gradient screening, validation of moderate immunopathological models, and studies of the synergistic immune effects of complex peptide complexes. It provides highly discriminative and authoritative experimental data for advanced immunophysiological and immunopathological applications.

Core Product Advantages

1. Doubled Physiological Immune Enhancement: Doubling the effective concentration compared to the basic 5mg formulation, it comprehensively enhances thymus-dependent T cell maturation and immune reconstitution, completely overcoming the limitations of limited efficacy of low-dose thymosin α1 variants.

2. Enhanced Dual Immune Homeostasis Regulation: Further optimizing the balance of pro-inflammatory and anti-inflammatory cytokines, achieving more precise correction of immune biases, and effectively intervening in moderate immune-inflammatory imbalances that cannot be fully improved by the basic formulation.

3. Broad Advanced Research Adaptability: Suitable for advanced immunodeficiency mechanism research, modeling of moderate inflammatory immune diseases, and validation of high-efficiency peptide synergistic immune regulation, covering a wider range of preclinical research scenarios than the basic formulation. 4. High-stability pharmaceutical-grade purification process: Utilizing upgraded multi-stage gradient deep purification and vacuum lyophilization technology, the active molecular structure is fully preserved, with zero impurity interference and ultra-pure experimental variables, ensuring the accuracy and reproducibility of advanced research conclusions.

5. High-standard aseptic packaging: Packaged in 10-vial integrated dust-free aseptic packaging, each batch undergoes rigorous full-item HPLC purity testing and comes with a complete official Certificate of Account (COA). This product exhibits long-term stable activity retention characteristics and is widely applicable to advanced laboratory immunological mechanism research, high-standard preclinical immunological projects, and global high-end bulk customized procurement.

Thymosin α1 TA10 10mg*10 vials (Thymosin α1) belongs to the immunopeptide class and is a medium-potency upgraded version of the thymosin α1 peptide series. Its concentration is twice that of the original product.